FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207017269> ?p ?o ?g. }

• W4207017269 endingPage "i167" @default.
• W4207017269 startingPage "i166" @default.
• W4207017269 abstract "Abstract Background Janus Kinases (JAK), including JAK1, JAK2, JAK3 and TYK2, have garnered increasing interest as therapeutic targets for several chronic inflammatory diseases such as inflammatory bowel disease (IBD). Although oral small molecule JAK inhibitors are being used in the clinics as an effective treatment for moderate-to-severe ulcerative colitis, nonethelessthey can lead to severe systemic immunosuppression, which is associated with an increased risk of infections. Our project aimed to develop a nanomedicine that induced JAK1 mRNA degradation within the intestinal mucosa with little systemic distribution. Methods The NEWDEAL project (H2020) developed both potent small interfering RNAs (siRNA) specific for JAK1 (siJAK1) or TNF (siTNF), and lipid nanoparticles (CL40) as nano-vectors. Their biodistribution in a mice colitis model was analyzed using labeled AF488-siJAK1 complexed to CL40 and given intrarectally (IR) for 3 consecutive days. In vivo cellular uptake was determined by FACS analysis. To induce colitis, C57/Bl6 mice received 2.5% dextrate sulfate sodium (DSS) in drinking water for 5 days. To determine efficacy of siRNAs, mice started DSS on day 0 and received IR administrations of siRNAs alone or complexed with CL40 nanoparticles on days -3, -2, -1, 1, 3, 5 and 7. On day 9, mice were sacrificed and disease activity index (DAI), histological score, fecal inflammatory markers and qPCR of targeted genes were analyzed. Results Colonic phagocytic cells - such as macrophages, neutrophils and monocytes - are the main targets cells of the siRNA-CL40 nanocomplexes following IR administration. A small percentage of cells in the draining lymph nodes captured siRNA CL40 nanocomplexes, remaining almost undetectable in spleen. This suggests a localized effect of the siRNA nanocomplexes after IR administration. While siJAK1-alone effectively reduced JAK1 mRNA expression in the distal colon, it did not improve intestinal inflammation induced by administering DSS. siTNF-CL40 treatment, though not siTNF-alone, significantly decreased intestinal inflammation in the DSS colitis model of treated mice, revealing significant protection from weight loss, lower histological scores, and reduced production of fecal lipocalin. Conclusion In summary, these results show that despite effectively reducing JAK1 mRNA expression, siJAK1 administration does not ameliorate colitis in a DSS mice model. However, we showed that a locally delivered siTNF-nanocomplex has the capacity to improve clinical, macroscopic and histological symptoms as well as fecal biomarkers in DSS colitic mice. We conclude not only that siRNA-CL40 target delivery is a good therapeutic strategy, but also that siTNF-CL40 is effective in locally treating intestinal inflammation." @default.
• W4207017269 created "2022-01-26" @default.
• W4207017269 creator A5003110378 @default.
• W4207017269 creator A5008552726 @default.
• W4207017269 creator A5011931030 @default.
• W4207017269 creator A5029103273 @default.
• W4207017269 creator A5032725945 @default.
• W4207017269 creator A5039924630 @default.
• W4207017269 creator A5053836859 @default.
• W4207017269 creator A5084512446 @default.
• W4207017269 creator A5084515363 @default.
• W4207017269 creator A5090218857 @default.
• W4207017269 date "2022-01-01" @default.
• W4207017269 modified "2023-10-09" @default.
• W4207017269 title "P056 Local nanocarrier delivery of JAK1 siRNA for IBD treatment: an in vivo mouse model" @default.
• W4207017269 doi "https://doi.org/10.1093/ecco-jcc/jjab232.185" @default.
• W4207017269 hasPublicationYear "2022" @default.
• W4207017269 type Work @default.
• W4207017269 citedByCount "0" @default.
• W4207017269 crossrefType "journal-article" @default.
• W4207017269 hasAuthorship W4207017269A5003110378 @default.
• W4207017269 hasAuthorship W4207017269A5008552726 @default.
• W4207017269 hasAuthorship W4207017269A5011931030 @default.
• W4207017269 hasAuthorship W4207017269A5029103273 @default.
• W4207017269 hasAuthorship W4207017269A5032725945 @default.
• W4207017269 hasAuthorship W4207017269A5039924630 @default.
• W4207017269 hasAuthorship W4207017269A5053836859 @default.
• W4207017269 hasAuthorship W4207017269A5084512446 @default.
• W4207017269 hasAuthorship W4207017269A5084515363 @default.
• W4207017269 hasAuthorship W4207017269A5090218857 @default.
• W4207017269 hasBestOaLocation W42070172691 @default.
• W4207017269 hasConcept C126322002 @default.
• W4207017269 hasConcept C150903083 @default.
• W4207017269 hasConcept C18150654 @default.
• W4207017269 hasConcept C185592680 @default.
• W4207017269 hasConcept C203014093 @default.
• W4207017269 hasConcept C207001950 @default.
• W4207017269 hasConcept C22615655 @default.
• W4207017269 hasConcept C2775862500 @default.
• W4207017269 hasConcept C2778260677 @default.
• W4207017269 hasConcept C2779134260 @default.
• W4207017269 hasConcept C2780035454 @default.
• W4207017269 hasConcept C54009773 @default.
• W4207017269 hasConcept C54355233 @default.
• W4207017269 hasConcept C71924100 @default.
• W4207017269 hasConcept C81885089 @default.
• W4207017269 hasConcept C86803240 @default.
• W4207017269 hasConcept C98274493 @default.
• W4207017269 hasConceptScore W4207017269C126322002 @default.
• W4207017269 hasConceptScore W4207017269C150903083 @default.
• W4207017269 hasConceptScore W4207017269C18150654 @default.
• W4207017269 hasConceptScore W4207017269C185592680 @default.
• W4207017269 hasConceptScore W4207017269C203014093 @default.
• W4207017269 hasConceptScore W4207017269C207001950 @default.
• W4207017269 hasConceptScore W4207017269C22615655 @default.
• W4207017269 hasConceptScore W4207017269C2775862500 @default.
• W4207017269 hasConceptScore W4207017269C2778260677 @default.
• W4207017269 hasConceptScore W4207017269C2779134260 @default.
• W4207017269 hasConceptScore W4207017269C2780035454 @default.
• W4207017269 hasConceptScore W4207017269C54009773 @default.
• W4207017269 hasConceptScore W4207017269C54355233 @default.
• W4207017269 hasConceptScore W4207017269C71924100 @default.
• W4207017269 hasConceptScore W4207017269C81885089 @default.
• W4207017269 hasConceptScore W4207017269C86803240 @default.
• W4207017269 hasConceptScore W4207017269C98274493 @default.
• W4207017269 hasIssue "Supplement_1" @default.
• W4207017269 hasLocation W42070172691 @default.
• W4207017269 hasOpenAccess W4207017269 @default.
• W4207017269 hasPrimaryLocation W42070172691 @default.
• W4207017269 hasRelatedWork W1986912627 @default.
• W4207017269 hasRelatedWork W1992682676 @default.
• W4207017269 hasRelatedWork W2036679073 @default.
• W4207017269 hasRelatedWork W2083741917 @default.
• W4207017269 hasRelatedWork W2497503243 @default.
• W4207017269 hasRelatedWork W2736320493 @default.
• W4207017269 hasRelatedWork W3036327439 @default.
• W4207017269 hasRelatedWork W3196688930 @default.
• W4207017269 hasRelatedWork W4206655496 @default.
• W4207017269 hasRelatedWork W4283755730 @default.
• W4207017269 hasVolume "16" @default.
• W4207017269 isParatext "false" @default.
• W4207017269 isRetracted "false" @default.
• W4207017269 workType "article" @default.